Skip to main content
. 2020 Jul 27;6(7):e04321. doi: 10.1016/j.heliyon.2020.e04321

Table 3.

Dentists' answer to the question “Regardless of indications for therapy, the duration of BP or antiresorptive therapy continues to be a risk factor for developing MRONJ”.

Dentist's answer Frequency Percent Cumulative Percent
Yes 24 32.4 32.4
No 3 4.1 36.5
Don't Know 47 63.5 100.0
Total 74 100.0